TrademarkDir
EVEREST MEDICINES
DEAD

Serial Number

88584513

Owner

EverNov Medicines Limited

Attorney

David Devernoe

Filing Date

Aug 19, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EVEREST MEDICINES Trademark

Serial Number: 88584513

EVEREST MEDICINES is a trademark filed by EverNov Medicines Limited on August 19, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EverNov Medicines Limited (3 trademarks)

West Nanjing 1266
Shanghai 200040 , CN

Entity Type: 16

Trademark Details

Filing Date

August 19, 2019

Registration Date

Not Registered

Published for Opposition

August 4, 2020

Goods & Services

Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical research; pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health

Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 25, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 25, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2023 EXRA
SOU EXTENSION 5 GRANTED
Aug 16, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 16, 2023 AITU
SOU EXTENSION 5 FILED
Aug 9, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jan 17, 2023 EX4G
SOU EXTENSION 4 FILED
Jan 17, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2022 EXRA
SOU EXTENSION 3 GRANTED
Aug 18, 2022 EX3G
SOU EXTENSION 3 FILED
Aug 18, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2022 EXRA
SOU EXTENSION 2 GRANTED
Feb 4, 2022 EX2G
SOU EXTENSION 2 FILED
Feb 4, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2021 EXRA
SOU EXTENSION 1 GRANTED
Aug 18, 2021 EX1G
SOU EXTENSION 1 FILED
Aug 18, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 18, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 23, 2021 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jan 13, 2021 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 6, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2020 CNSA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2020 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2020 TROA
ASSIGNED TO PETITION STAFF
Jun 24, 2020 APET
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2020 CNRT
ASSIGNED TO EXAMINER
May 20, 2020 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 20, 2019 CHAN
ASSIGNED TO LIE
Dec 13, 2019 ALIE
FAX RECEIVED
Dec 4, 2019 FAXX
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2019 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Oct 16, 2019 LOPT
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 5, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2019 NWOS
NEW APPLICATION ENTERED
Aug 22, 2019 NWAP

Related Trademarks

More from this Owner

EVEREST

EVEREST

EVEREST

EVEREST

EVEREST MEDICINES

EVEREST MEDICINES

EVEREST MEDICINES

EVEREST MEDICINES